Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65. (Q39804120)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

title

Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

main subject

apoptotic process

0 references

artesunate

0 references

author name string

Shihui Li

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

Fang Xue

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

Zhiyong Cheng

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

Xiaoyang Yang

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

Suyun Wang

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

Fengyong Geng

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

Ling Pan

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

publication date

29 August 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

published in

International Journal of Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

volume

90

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

page(s)

513-521

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

cites work

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS12185-009-0409-Z

retrieved

21 January 2018

The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular modes of action of artesunate in tumor cell lines.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cell "dead or alive": caspase and survivin regulate cell death, cell cycle and cell survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of Malaria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-malarial artesunate is also active against cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel Therapies in Multiple Myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728025

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S12185-009-0409-Z

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

PubMed publication ID

19728025

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728025

retrieved

14 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39804120&oldid=2203186399"